Gamida Cell to delist as Highbridge takes full possession
Israeli stem cell remedy firm Gamida Cell (Nasdaq: GMDA) has introduced that Highbridge Capital Administration, the corporate's principal lender, ...
Israeli stem cell remedy firm Gamida Cell (Nasdaq: GMDA) has introduced that Highbridge Capital Administration, the corporate's principal lender, ...
Copyright © 2012 The Connecting Newspaper | All Rights Reserved.